NEUROFIT offers a large range of models and assays for evaluating neurotoxicity, neuroprotection or neurotrophic activity of new test compounds.
We develop custom protocols to determine mechanism of action, or define therapeutic indication of new drug candidates.
Neuro-inflammation is now considered as a common feature of most of neurodegenerative diseases. Neurofit proposes neuro-inflammatory cellular models to be in line with this hallmark and to assess the properties of your compounds.
Neuroinflammation is now recognized as a critical process in different neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, stroke, multiple sclerosis...